Non-Invasive Cardiac Output Monitor in Children

NCT ID: NCT03869606

Last Updated: 2020-07-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-04-01

Study Completion Date

2020-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will be the first of several studies that establish the value of measuring fluid responsiveness in children undergoing general anesthesia. The first study in this series will determine whether fluid responsiveness, as measured with the NICOM cardiac output monitor in normal children before and after passive leg raising, predicts changes in stroke volume, cardiac output, and blood pressure during the early stages of anesthesia. A second study will determine if early treatment of the fluid responsiveness will prevent the decline in blood pressure that accompanies general anesthesia. If the NICOM monitor permits accurate prediction in normal patients, future studies of pediatric patients undergoing major surgery would be indicated.

The investigators would like to add 25 additional patients who will have the NICOM assessments performed in the pre operative area - Pre anesthesia. General anesthesia may alter the results of the NICOM assessments. The investigators will use these 25 subjects to serve as a comparison/control group.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Eligible patients will be identified from the surgery schedule and will be contacted by a research team member via phone ahead of their surgery date to inform them of the research study. This call will allow the research team member to answer questions and establish the subject's interest in participation. If interested, or not able to be contacted by phone, patient/family will be approached in the pre-operative area or other private hospital setting. He/she and their parent(s) will have ample time to read the consent and ask any questions regarding the study.

If the subject and his/her parent(s) agree to participate, all standard techniques for general anesthesia compatible with the particular surgical procedure will be employed. Clinical decisions concerning the subject's perioperative care will be made by the anesthesiologist of record.

Cardiac output will be measured with the NICOM cardiac output monitor. The NICOM is a non-invasive monitor using bioreactance, a proprietary technique developed by Cheetah Medical that utilizes delay time shifts to measure stroke volume when an alternating current is passed through the thorax. It requires the placement of four surface electrodes (similar to ECG electrodes) above and below the heart on each side of the patient's chest.

This study will measure cardiac output, stroke volume, and fluid responsiveness (increase in stroke volume \> 10%) obtained via passive leg elevation immediately after induction of anesthesia. Adult studies have demonstrated that fifty percent of fasted patients are fluid responsive. The investigators seek to determine the incidence on children.

All decisions concerning clinical care of the subject during the perioperative period will made by the anesthesiologist of record in accordance with accepted standard of care.

1. The NICOM® electrodes will be applied in proper position in the pre-op area. In pre-op, baseline and passive leg measurements will be recorded using the NICOM®. Electrodes will remain in place and will again be used during the OR NICOM® measurements.
2. Standard physiologic monitors will be used: non-invasive blood pressure, ECG, pulse oximeter, capnograph (end-tidal carbon dioxide), BIS (bispectral analsysis/depth of anesthesia).
3. Induction of anesthesia to be determined by the anesthesiologist of record. May be either inhalation or intravenous.
4. Measurements recorded after application of NICOM electrodes include blood pressure, heart rate, end-tidal carbon dioxide, arterial oxygen saturation, BIS level, stroke volume, cardiac output.
5. After measurement of baseline cardiorespiratory parameters, passive leg elevation to 45 degrees will be performed.
6. Cardiorespiratory measurements describe in section d will be repeated after passive leg elevation.
7. Cardiorespiratory parameters will be measured during the next 60 minutes of anesthesia. This information will be used to determine whether fluid responsive patients require additional intravenous fluids or vasoactive drugs during the course of anesthesia.

The same procedures listed above will be performed Pre-anesthesia in the Pre operative area, while the subject is fully awake.

General anesthesia may alter the results of the NICOM procedures. The investigators will add 25 patients who will be evaluated with the study procedures pre anesthesia as a control/comparison group.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Output, Low Pediatric

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NICOM by Cheetah Medical

Observational measurement, Cardiac Output, Pre- and Post Anesthesia

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients 11 to no older than 17 years of age

Exclusion Criteria

* severed developmental delay,
* orthopedic patients with leg injuries
* injury that would prevent passive leg elevation.
* severe aortic insufficiency,
* severe anatomic abnormalities of the thoracic aorta
* patients with external cardiac pacemakers. close
Minimum Eligible Age

11 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Indiana University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Andrew Stasic

Associate Professor of Anesthesia

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Andrew F Stasic, MD

Role: PRINCIPAL_INVESTIGATOR

Indiana University School of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Riley Hospital for Children

Indianapolis, Indiana, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1808715198

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Diversion Device With Breath Control
NCT04208984 NOT_YET_RECRUITING